GIP or GIPR inhibition protects mice from diet-induced obesity, and administration of long-lasting GIP derivatives or transgenic overexpression of GIP has an anti-obesity effect [5,6,7]. Here, GIP is linked to obesity due to melanocortin 4 receptor deficiency.